244 related articles for article (PubMed ID: 32256068)
1. Paclitaxel-Loaded Macrophage Membrane Camouflaged Albumin Nanoparticles for Targeted Cancer Therapy.
Cao X; Tan T; Zhu D; Yu H; Liu Y; Zhou H; Jin Y; Xia Q
Int J Nanomedicine; 2020; 15():1915-1928. PubMed ID: 32256068
[TBL] [Abstract][Full Text] [Related]
2. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
Xu C; Liu W; Hu Y; Li W; Di W
Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
[TBL] [Abstract][Full Text] [Related]
3. Liposome encapsulated albumin-paclitaxel nanoparticle for enhanced antitumor efficacy.
Ruttala HB; Ko YT
Pharm Res; 2015 Mar; 32(3):1002-16. PubMed ID: 25213777
[TBL] [Abstract][Full Text] [Related]
4. Bio-Mimicking Nanoparticles for Targeted Therapy of Malignant Melanoma.
Zhou X; Yu R; Cao X; Zhang ZR; Deng L
J Biomed Nanotechnol; 2019 May; 15(5):993-1004. PubMed ID: 30890230
[TBL] [Abstract][Full Text] [Related]
5. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
[TBL] [Abstract][Full Text] [Related]
6. Long-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumulation of hydrophobic anticancer drug.
Battogtokh G; Kang JH; Ko YT
Eur J Pharm Biopharm; 2015 Oct; 96():96-105. PubMed ID: 26212785
[TBL] [Abstract][Full Text] [Related]
7. Albumin-coated nanocrystals for carrier-free delivery of paclitaxel.
Park J; Sun B; Yeo Y
J Control Release; 2017 Oct; 263():90-101. PubMed ID: 28049022
[TBL] [Abstract][Full Text] [Related]
8. Leutusome: A Biomimetic Nanoplatform Integrating Plasma Membrane Components of Leukocytes and Tumor Cells for Remarkably Enhanced Solid Tumor Homing.
He H; Guo C; Wang J; Korzun WJ; Wang XY; Ghosh S; Yang H
Nano Lett; 2018 Oct; 18(10):6164-6174. PubMed ID: 30207473
[TBL] [Abstract][Full Text] [Related]
9. Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs.
Zhang L; Yao J; Zhou J; Wang T; Zhang Q
Int J Pharm; 2013 Jan; 441(1-2):654-64. PubMed ID: 23117024
[TBL] [Abstract][Full Text] [Related]
10. The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models.
Zhang W; Shi Y; Chen Y; Hao J; Sha X; Fang X
Biomaterials; 2011 Sep; 32(25):5934-44. PubMed ID: 21596432
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel-loaded redox-sensitive nanoparticles based on hyaluronic acid-vitamin E succinate conjugates for improved lung cancer treatment.
Song Y; Cai H; Yin T; Huo M; Ma P; Zhou J; Lai W
Int J Nanomedicine; 2018; 13():1585-1600. PubMed ID: 29588586
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel-loaded polymeric nanoparticles based on α-tocopheryl succinate for the treatment of head and neck squamous cell carcinoma:
Riestra-Ayora J; Sánchez-Rodríguez C; Palao-Suay R; Yanes-Díaz J; Martín-Hita A; Aguilar MR; Sanz-Fernández R
Drug Deliv; 2021 Dec; 28(1):1376-1388. PubMed ID: 34180747
[TBL] [Abstract][Full Text] [Related]
13. Macrophage-Membrane-Coated Nanoparticles for Tumor-Targeted Chemotherapy.
Zhang Y; Cai K; Li C; Guo Q; Chen Q; He X; Liu L; Zhang Y; Lu Y; Chen X; Sun T; Huang Y; Cheng J; Jiang C
Nano Lett; 2018 Mar; 18(3):1908-1915. PubMed ID: 29473753
[TBL] [Abstract][Full Text] [Related]
14. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
15. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
16. Development of paclitaxel loaded pegylated gelatin targeted nanoparticles for improved treatment efficacy in non-small cell lung cancer (NSCLC): an in vitro and in vivo evaluation study.
Gu M; Luan J; Song K; Qiu C; Zhang X; Zhang M
Acta Biochim Pol; 2021 Aug; 68(4):583-591. PubMed ID: 34355554
[TBL] [Abstract][Full Text] [Related]
17. Biological evaluation of PEG modified nanosuspensions based on human serum albumin for tumor targeted delivery of paclitaxel.
Yin T; Cai H; Liu J; Cui B; Wang L; Yin L; Zhou J; Huo M
Eur J Pharm Sci; 2016 Feb; 83():79-87. PubMed ID: 26699227
[TBL] [Abstract][Full Text] [Related]
18. Dual drugs (microRNA-34a and paclitaxel)-loaded functional solid lipid nanoparticles for synergistic cancer cell suppression.
Shi S; Han L; Deng L; Zhang Y; Shen H; Gong T; Zhang Z; Sun X
J Control Release; 2014 Nov; 194():228-37. PubMed ID: 25220161
[TBL] [Abstract][Full Text] [Related]
19. A reconstituted thermosensitive hydrogel system based on paclitaxel-loaded amphiphilic copolymer nanoparticles and antitumor efficacy.
Liang Y; Dong C; Zhang J; Deng L; Dong A
Drug Dev Ind Pharm; 2017 Jun; 43(6):972-979. PubMed ID: 28121206
[TBL] [Abstract][Full Text] [Related]
20. Porous quaternized chitosan nanoparticles containing paclitaxel nanocrystals improved therapeutic efficacy in non-small-cell lung cancer after oral administration.
Lv PP; Wei W; Yue H; Yang TY; Wang LY; Ma GH
Biomacromolecules; 2011 Dec; 12(12):4230-9. PubMed ID: 22044456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
